Literature DB >> 33352955

Peptide-Peptide Co-Assembly: A Design Strategy for Functional Detection of C-peptide, A Biomarker of Diabetic Neuropathy.

Kiat Hwa Chan1, Jaehong Lim2, Joo Eun Jee2, Jia Hui Aw1, Su Seong Lee2.   

Abstract

Diabetes-related neuropathy is a debilitating condition that may be averted if it can be detected early. One possible way this can be achieved at low cost is to utilise peptides to detect C-peptide, a biomarker of diabetic neuropathy. This depends on peptide-peptide co-assembly, which is currently in a nascent stage of intense study. Instead, we propose a bead-based triple-overlay combinatorial strategy that can preserve inter-residue information during the screening process for a suitable complementary peptide to co-assemble with C-peptide. The screening process commenced with a pentapeptide general library, which revealed histidine to be an essential residue. Further screening with seven tetrapeptide focused libraries led to a table of self-consistent peptide sequences that included tryptophan and lysine at high frequencies. Three complementary nonapeptides (9mer com-peptides), wpkkhfwgq (Trp-D), kwkkhfwgq (Lys-D), and KWKKHFWGQ (Lys-L) (as a negative control) were picked from this table for co-assembly studies with C-peptide. Attenuated total reflectance Fourier transform infrared (ATR-FTIR) and circular dichroism (CD) spectroscopies were utilized to study inter-peptide interactions and changes in secondary structures respectively. ATR-FTIR studies showed that there is indeed inter-peptide interaction between C-peptide and the tryptophan residues of the 9mer com-peptides. CD studies of unaggregated and colloidal C-peptide with the 9mer com-peptides suggest that the extent of co-assembly of C-peptide with Trp-D is greatest, followed by Lys-D and Lys-L. These results are promising and indicate that the presented strategy is viable for designing and evaluating longer complementary peptides, as well as complementary peptides for co-assembly with other polypeptides of interest and importance. We discuss the possibility of designing complementary peptides to inhibit toxic amyloidosis with this approach.

Entities:  

Keywords:  C-peptide; amyloidosis; biomarker; co-assembly; design; detection; diabetic neuropathy; inhibition; peptide-peptide

Mesh:

Substances:

Year:  2020        PMID: 33352955      PMCID: PMC7766332          DOI: 10.3390/ijms21249671

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  55 in total

Review 1.  Inhibition of amyloid formation.

Authors:  Torleif Härd; Christofer Lendel
Journal:  J Mol Biol       Date:  2012-01-05       Impact factor: 5.469

2.  Template-assisted and self-activating clicked peptide as a synthetic mimic of the SH2 domain.

Authors:  Katsunori Tanaka; Sanae Shirotsuki; Takayuki Iwata; Chika Kageyama; Tsuyoshi Tahara; Satoshi Nozaki; Eric R O Siwu; Satoru Tamura; Shunsuke Douke; Nobutoshi Murakami; Hirotaka Onoe; Yasuyoshi Watanabe; Koichi Fukase
Journal:  ACS Chem Biol       Date:  2012-01-26       Impact factor: 5.100

Review 3.  Short peptides as biosensor transducers.

Authors:  Silvia Pavan; Federico Berti
Journal:  Anal Bioanal Chem       Date:  2011-12-15       Impact factor: 4.142

4.  Formation of colloidal suspension of hydrophobic compounds with an amphiphilic self-assembling peptide.

Authors:  S Y Fung; H Yang; P Chen
Journal:  Colloids Surf B Biointerfaces       Date:  2006-12-14       Impact factor: 5.268

5.  High-throughput identification of substrate specificity for protein kinase by using an improved one-bead-one-compound library approach.

Authors:  Yun-Gon Kim; Dong-Sik Shin; Eun-Mi Kim; Hyung-Yeon Park; Chang-Soo Lee; June-Hyung Kim; Bon-Su Lee; Yoon-Sik Lee; Byung-Gee Kim
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

Review 6.  Inhibition of Amyloid Fibrillation by Small Molecules and Nanomaterials: Strategic Development of Pharmaceuticals Against Amyloidosis.

Authors:  Vandna Sharma; Kalyan Sundar Ghosh
Journal:  Protein Pept Lett       Date:  2019       Impact factor: 1.890

7.  Structural features of proinsulin C-peptide oligomeric and amyloid states.

Authors:  Jesper Lind; Emma Lindahl; Alex Perálvarez-Marín; Anna Holmlund; Hans Jörnvall; Lena Mäler
Journal:  FEBS J       Date:  2010-08-03       Impact factor: 5.542

Review 8.  The clinical utility of C-peptide measurement in the care of patients with diabetes.

Authors:  A G Jones; A T Hattersley
Journal:  Diabet Med       Date:  2013-07       Impact factor: 4.359

Review 9.  A Comprehensive Review on Current Advances in Peptide Drug Development and Design.

Authors:  Andy Chi-Lung Lee; Janelle Louise Harris; Kum Kum Khanna; Ji-Hong Hong
Journal:  Int J Mol Sci       Date:  2019-05-14       Impact factor: 5.923

10.  De novo design and experimental characterization of ultrashort self-associating peptides.

Authors:  James Smadbeck; Kiat Hwa Chan; George A Khoury; Bo Xue; Robert C Robinson; Charlotte A E Hauser; Christodoulos A Floudas
Journal:  PLoS Comput Biol       Date:  2014-07-10       Impact factor: 4.475

View more
  4 in total

1.  The Self-Assembly and Design of Polyfunctional Nanosystems.

Authors:  Ruslan Kashapov; Lucia Zakharova
Journal:  Int J Mol Sci       Date:  2021-02-23       Impact factor: 5.923

2.  Targeted Delivery of Nanovaccine to Dendritic Cells via DC-Binding Peptides Induces Potent Antiviral Immunity in vivo.

Authors:  Ying Lu; Ze-Hui Liu; Ying-Xiang Li; Hui-Ling Xu; Wei-Huan Fang; Fang He
Journal:  Int J Nanomedicine       Date:  2022-04-05

3.  Toward Development of a Label-Free Detection Technique for Microfluidic Fluorometric Peptide-Based Biosensor Systems.

Authors:  Nikita Sitkov; Tatiana Zimina; Alexander Kolobov; Vladimir Karasev; Alexander Romanov; Viktor Luchinin; Dmitry Kaplun
Journal:  Micromachines (Basel)       Date:  2021-06-13       Impact factor: 2.891

4.  A Novel Peptide as a Specific and Selective Probe for Klebsiella pneumoniae Detection.

Authors:  Hyun Kim; Ju Hye Jang; In Young Jung; Ju Hyun Cho
Journal:  Biosensors (Basel)       Date:  2022-03-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.